MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Profit Margin

As of the most recent data (March 2026), MTACU shows a profit margin of -128.73%. That compares with -89.38% in the prior-year period — down 44.0% year over year. That is below the sector sector average of 19.74%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MTACU's profit margin is now -128.73% (was -89.38%) — a 44.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) is outperforming or lagging.

The its sector sector average profit margin is about 19.74%. MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) is at -128.73%, which is lower that average. That is roughly 752.2% below the sector mean. Use the comparison chart on this page to see how MTACU stacks up against individual peers as well.

That compares with -89.38% in the prior-year period — down 44.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -128.73%) with ownership activity and broader fundamentals.